Analyst Ratings for Magellan Health Inc. (MGLN)Updated: 2017-07-27
Shares of Magellan Health Inc. (NASDAQ:MGLN) have received a consensus rating of Hold from Wall Street analysts. A consensus rating of Hold was previously issued for MGLN last month.
2 analysts declared MGLN a buy, 0 gave an overweight rating, 2 issued a hold rating, 0 gave an underweight rating, and 1 gave a sell rating. Compared to three months ago, there has been an increase of 1 in the number of analysts with a positive outlook on the stock. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.
A number of analysts gave price targets for MGLN. The highest price target was 91, implying potential capital gains of 15.63 percent. The minimum price target given was 69, implying a possible loss of -12.33 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.
Analysts have revised their earnings estimates downwards for this quarter, by about -6.2 percent on average, compared to last month. This can be compared with the average change in earnings estimates over the past 3 months, which is -2.19 percent. Meanwhile, fiscal year estimates have been revised downwards by -3.8 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 1.86 percent.
Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. Over the past month, 0 analysts increased their quarterly estimates, while 2 analysts revised their estimates downwards. Also over the last month, 0 analysts increased their estimates for the FY earnings, while 1 analysts made negative revisions to their fiscal year's estimates.
Analysts estimate earnings of MGLN to grow at a rate of 27.6 percent. It's possible to gain additional insight about growth valuation of a company by looking at the PEG ratio. Investors like to see smaller values for the PEG ratio, as that can indicate whether the high price level of a stock is warranted by high growth. Wall Street investors typically prefer a PEG ratio to be smaller than 1, though it could be better to see where the ratio stands relative to peers in the industry. The PEG ratio of MGLN is 0.82.
In the trailing 52-weeks, MGLN hit 84.71 at the highest peak, while it's lowest trading point was 49.50. Today's price is 58.99 percent above the 52-week low, and 7.09 percent below the high. MGLN has a price/earnings ratio of 22.7. Investors typically compare the P/E ratio to a company's peers in the industry. The MGLN value stock report compares MGLN to some of its peers using value stock charts. The market cap of MGLN is $1.88 billion. MGLN will post this quarters earnings in days, on 0000-00-00.